The U.S. Food and Drug Administration has issued a Class I recall of Exel/Exelint Huber needles, Exel/Exelint Huber Infusion Sets and Exel/Exelint “Securetouch+” Safety Huber Infusion Sets, ...
"According to the latest research study, the demand of global Huber Needles Market size & share in terms of revenue was valued at USD 48 million in 2022 and it is expected to surpass around USD 78 ...
NEW YORK, April 30, 2018 /PRNewswire/ -- Persistence Market Research provides key insights and forecast on the global Huber needles market for the forecast period 2017-2024.The primary objective of ...
(MENAFN- GetNews) As global demand for implantable port access devices continues to grow, Huber needles have become an essential medical consumable in oncology, infusion therapy, and long-term venous ...
January 26, 2010 (WASHINGTON) The Food and Drug Administration said Japan-based Nipro Medical Corp. has voluntarily recalled its Exel/Exelint Huber needles manufactured between January 2007 and August ...
SEATTLE--(BUSINESS WIRE)--According to Coherent Market Insights, the U.S. Safety Needles market is estimated to be valued at US$ 2,447.3 million in 2020 and is expected to exhibit a CAGR of 4.8% over ...